Advances in the pharmacological treatment of ADHD
Attention deficit hyperactivity disorder (ADHD) affects approximately 3–10% of the school-aged population and 2–5% of adults. ADHD begins in childhood, but often persists into adulthood, making treatment across the life cycle crucial.
ADHD in practice 2015; 7(1): 16–19
To continue reading this article, please sign in or register.